Great news, Dr. Marie Standl, member of the HELICAP Scientific Advisory Board and Head of Research Group 'Allergic Disease Epidemiology' has been awarded with an ERC starting grant for pioneering health research at Helmholtz Zentrum München. Dr. Marie Standl aims to identify biomarkers that predict the development and progression of allergic diseases and ultimately, to support intervention strategies for people at risk of developing allergic diseases.
https://www.helmholtz-muenchen.de/en/aktuelles/latest-news/press-information-news/article/48796/index.html